Contrast agents for myocardial perfusion imaging
AssigneeLantheus Medical Imaging, Inc.
InventorsDavid S. Casebier, Simon P. Robinson, Ajay Purohit, Heike S. Radeke, Michael T. Azure, Douglas D. Dischino
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed, in part, to compounds and methods for imaging myocardial perfusion, comprising administering to a patient a contrast agent which comprises a compound that binds MC-1, and an imaging moiety, and scanning the patient using diagnostic imaging.
Claims4
A method for detecting, imaging or monitoring myocardial perfusion, comprising:
- administering to a patient a sterile formulation comprising a compound of the following formula:
- scanning the patient using diagnostic imaging.
A method for detecting, imaging, or monitoring myocardial perfusion, comprising:
- administering to a patient a contrast agent;
- and
- scanning the patient using diagnostic imaging,
- wherein the contrast agent is
A method for detecting, imaging, or monitoring myocardial perfusion, comprising:
- administering to a patient a contrast agent;
- and
- scanning the patient using diagnostic imaging,
- wherein the contrast agent is
A method for detecting, imaging, or monitoring myocardial perfusion, comprising:
- administering to a patient a contrast agent;
- and
- scanning the patient using diagnostic imaging,
- wherein the contrast agent is
Dependencies are inferred from the claim text.